Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,106 | 63,032 | 71,396 | 53,804 | 91,877 |
| Marketable Securities | 71,391 | 114,648 | 141,891 | 47,946 | 52,379 |
| Receivables | N/A | N/A | N/A | 120 | 17 |
| Other current assets | 421 | 674 | 15,626 | 16,385 | 16,544 |
| TOTAL | $137,889 | $181,293 | $231,406 | $121,287 | $163,765 |
| Non-Current Assets | |||||
| PPE Net | 18,816 | 20,572 | 22,046 | 23,828 | 24,956 |
| Other Non-Current Assets | 138,025 | 140,868 | 131,560 | 133,894 | 139,442 |
| TOTAL | $156,841 | $161,440 | $153,606 | $157,722 | $164,398 |
| Total Assets | $294,730 | $342,733 | $385,012 | $279,009 | $328,163 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,325 | 8,887 | 9,354 | 6,378 | 10,025 |
| Accrued Expenses | 8,098 | 12,600 | 11,000 | 12,158 | 9,191 |
| TOTAL | $36,289 | $37,448 | $35,019 | $34,109 | $34,288 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,320 | 7,824 | 6,951 | 8,315 | 8,214 |
| Other Non-Current Liabilities | 123,966 | 126,290 | 128,421 | 124,478 | 126,293 |
| TOTAL | $181,741 | $184,417 | $188,172 | $184,040 | $186,951 |
| Total Liabilities | $218,030 | $221,865 | $223,191 | $218,149 | $221,239 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180,618 | 180,552 | 180,511 | 134,574 | 131,295 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -937,476 | -888,354 | -842,275 | -791,693 | -739,102 |
| Other shareholders' equity | -1 | 82 | 33 | -10 | -15 |
| TOTAL | $76,700 | $120,868 | $161,821 | $60,860 | $106,924 |
| Total Liabilities And Equity | $294,730 | $342,733 | $385,012 | $279,009 | $328,163 |